Patent details

EP3429693 Title: NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF

Basic Information

Publication number:
EP3429693
PCT Application Number:
US2017022155
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177131273
PCT Publication Number:
WO2017160754
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF
French Title of Invention:
CONJUGUÉS ANTICORPS-MÉDICAMENT CIBLANT NAPI2B ET LEURS PROCÉDÉS D'UTILISATION
German Title of Invention:
GEGEN NAPI2B GERICHTETE ANTIKÖRPER-WIRKSTOFF-KONJUGATE UND VERFAHREN ZUR VERWENDUNG DAVON
SPC Number:

Dates

Filing date:
13/03/2017
Grant date:
23/08/2023
EP Publication Date:
23/01/2019
PCT Publication Date:
21/09/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/08/2023
EP B1 Publication Date:
23/08/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/03/2024
Expiration date:
13/03/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/08/2023
 
 

Name:
Mersana Therapeutics, Inc.
Address:
840 Memorial Drive, Cambridge, MA 02139, United States (US)

Inventor

1

Name:
POLING, Laura, L.
Address:
United States (US)

2

Name:
BODYAK, Natalya, D.
Address:
United States (US)

3

Name:
YURKOVETSKIY, Aleksandr, V.
Address:
United States (US)

4

Name:
BERGSTROM, Donald, A.
Address:
United States (US)

5

Name:
PARK, Peter, U.
Address:
United States (US)

6

Name:
LOWINGER, Timothy, B.
Address:
United States (US)

Priority

1

Priority Number:
201662308567 P
Priority Date:
15/03/2016
Priority Country:
United States (US)

2

Priority Number:
201662323068 P
Priority Date:
15/04/2016
Priority Country:
United States (US)

3

Priority Number:
201662383324 P
Priority Date:
02/09/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 47/68; A61P 35/00; A61K 47/59;

Publication

European Patent Bulletin

1

Issue number:
202334
Publication date:
23/08/2023
Description:
Grant (B1)

2

Issue number:
202339
Publication date:
27/09/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages